Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Shahzeb Khan

Showing results (1-10 of 492) with videos related to

Pageof 50
Sort By:
Current Diabetes Reports|October 11, 2020
What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?Muhammad Shahzeb Khan, Muthiah Vaduganathan
Journal of Diabetes|May 3, 2019
Heart failure prevention with sodium-glucose cotransporter 2 inhibitorsMuhammad Shahzeb Khan, Javed Butler
The American Journal of Medicine|November 20, 2018
The Rise of Documentation and the Destruction ofModern MedicineMuhammad Shahzeb Khan, Haris Riaz
Cardiac Failure Review|November 27, 2019
Sodium-Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 DiabetesMuhammad Shahzeb Khan, Javed Butler
The New England Journal of Medicine|July 16, 2020
Hydroxychloroquine as Postexposure Prophylaxis for Covid-19Muhammad-Shahzeb Khan, Javed Butler
JAMA|August 18, 2022
Stability of Changes in Health Status: Next Step in Comprehensively Assessing Patient-Reported OutcomesMuhammad Shahzeb Khan, Javed Butler
JACC. Basic to Translational Science|May 8, 2019
Targeting Mitochondrial Function in Heart Failure: Makes Sense But Will it Work?Muhammad Shahzeb Khan, Javed Butler
Journal of the American College of Cardiology|August 18, 2020
Heart Failure Prevention for All: Treatment Is Good, Prevention Is BetterJaved Butler, Muhammad Shahzeb Khan
JACC. Heart Failure|February 10, 2026
Lactate Dehydrogenase as a Systemic Biomarker: Revisiting an Old Marker for Heart FailureGuillaume Baudry, Muhammad Shahzeb Khan
JPMA. the Journal of the Pakistan Medical Association|March 11, 2014
Using myelin antigen--coupled autologous cells for treatment of multiple sclerosisFaizan Imran Bawany, Muhammad Shahzeb Khan
Pageof 50

Showing results (1-10 of 492) with videos related to

Sort By:
Pageof 50
Current Diabetes Reports|October 11, 2020
What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?Muhammad Shahzeb Khan, Muthiah Vaduganathan
Journal of Diabetes|May 3, 2019
Heart failure prevention with sodium-glucose cotransporter 2 inhibitorsMuhammad Shahzeb Khan, Javed Butler
The American Journal of Medicine|November 20, 2018
The Rise of Documentation and the Destruction ofModern MedicineMuhammad Shahzeb Khan, Haris Riaz
Cardiac Failure Review|November 27, 2019
Sodium-Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 DiabetesMuhammad Shahzeb Khan, Javed Butler
The New England Journal of Medicine|July 16, 2020
Hydroxychloroquine as Postexposure Prophylaxis for Covid-19Muhammad-Shahzeb Khan, Javed Butler
JAMA|August 18, 2022
Stability of Changes in Health Status: Next Step in Comprehensively Assessing Patient-Reported OutcomesMuhammad Shahzeb Khan, Javed Butler
JACC. Basic to Translational Science|May 8, 2019
Targeting Mitochondrial Function in Heart Failure: Makes Sense But Will it Work?Muhammad Shahzeb Khan, Javed Butler
Journal of the American College of Cardiology|August 18, 2020
Heart Failure Prevention for All: Treatment Is Good, Prevention Is BetterJaved Butler, Muhammad Shahzeb Khan
JACC. Heart Failure|February 10, 2026
Lactate Dehydrogenase as a Systemic Biomarker: Revisiting an Old Marker for Heart FailureGuillaume Baudry, Muhammad Shahzeb Khan
JPMA. the Journal of the Pakistan Medical Association|March 11, 2014
Using myelin antigen--coupled autologous cells for treatment of multiple sclerosisFaizan Imran Bawany, Muhammad Shahzeb Khan
Pageof 50